These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36992730)
1. Effective assay technologies fit for large-scale population screening of type 1 diabetes. Jia X; Yu L Front Clin Diabetes Healthc; 2022; 3():1034698. PubMed ID: 36992730 [TBL] [Abstract][Full Text] [Related]
2. High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease. He L; Jia X; Rasmussen CG; Waugh K; Miao D; Dong F; Frohnert B; Steck AK; Simmons KM; Rewers M; Yu L Diabetes Technol Ther; 2022 Jul; 24(7):502-509. PubMed ID: 35238620 [No Abstract] [Full Text] [Related]
3. Islet autoantibodies in disease prediction and pathogenesis. Jia X; Gu Y; High H; Yu L Diabetol Int; 2020 Jan; 11(1):6-10. PubMed ID: 31949998 [TBL] [Abstract][Full Text] [Related]
4. High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously. Gu Y; Zhao Z; Waugh K; Miao D; Jia X; Cheng J; Michels A; Rewers M; Yang T; Yu L EBioMedicine; 2019 Sep; 47():365-372. PubMed ID: 31447394 [TBL] [Abstract][Full Text] [Related]
5. Combined Detection of Islet Autoantibodies for Clinical Diagnosis of Type 1 Diabetes in the Low-Prevalence Population. Qi Y; Chen S; Chen H; Chen Y; Shi Y; Qin Y; Zhang M; Yang T; Gu Y J Clin Endocrinol Metab; 2023 May; 108(6):e326-e333. PubMed ID: 36480302 [TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases. Jia X; He L; Gu Y; High H; Yu L J Vis Exp; 2020 May; (159):. PubMed ID: 32538917 [TBL] [Abstract][Full Text] [Related]
7. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease. Zhao Z; Miao D; Michels A; Steck A; Dong F; Rewers M; Yu L J Immunol Methods; 2016 Mar; 430():28-32. PubMed ID: 26809048 [TBL] [Abstract][Full Text] [Related]
9. A High-throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19. Jia X; He L; Miao D; Zhang C; Rewers M; Yu L J Vis Exp; 2022 Jul; (185):. PubMed ID: 35876559 [TBL] [Abstract][Full Text] [Related]
10. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes. Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303 [TBL] [Abstract][Full Text] [Related]
11. Establishing reference intervals for islet autoantibodies in Han Chinese type 1 diabetes. Fu Y; Zhang C; Gu Y; Ge S; Li J; Feng J; Zhang L; Liu W; Chen H Scand J Clin Lab Invest; 2021 Dec; 81(8):641-648. PubMed ID: 34779329 [TBL] [Abstract][Full Text] [Related]
12. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk. Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L; Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486 [TBL] [Abstract][Full Text] [Related]
13. Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes. Jia X; Yu L J Endocr Soc; 2023 Dec; 8(1):bvad160. PubMed ID: 38169963 [TBL] [Abstract][Full Text] [Related]
14. "Life or death": Experiences of insulin insecurity among adults with type 1 diabetes in the United States. Willner S; Whittemore R; Keene D SSM Popul Health; 2020 Aug; 11():100624. PubMed ID: 32676533 [TBL] [Abstract][Full Text] [Related]
15. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children. Ng K; Anand V; Stavropoulos H; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Lou O; Hagopian W; Achenbach P; Diabetologia; 2023 Jan; 66(1):93-104. PubMed ID: 36195673 [TBL] [Abstract][Full Text] [Related]
16. Large-Scale Screening in General Population Children for Celiac Disease with a Multiplex Electrochemiluminescence (ECL) Assay. He L; Jia X; Gu Y; Miao D; Waugh K; Geno C; Liu E; Rewers M; Yu L J Immunol Res; 2020; 2020():8897656. PubMed ID: 33426098 [TBL] [Abstract][Full Text] [Related]
17. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes. Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD; Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582 [TBL] [Abstract][Full Text] [Related]
18. Novel autoantibodies to the Ī²-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes. Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115 [TBL] [Abstract][Full Text] [Related]
19. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes. Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014 [TBL] [Abstract][Full Text] [Related]
20. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes. Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK; Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]